Wednesday, March 22, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense Headlines – June 26, 2016

by Global Biodefense Staff
June 26, 2016
Health Security & Biodefense Headlines

See what we’re reading this week at Global Biodefense on topics including the life science – biodefense complex, local public health bracing for Zika, and clinical management of Ebola in children.

POLICY & PRACTICES

  • How D.C. is preparing for nuclear, chemical, and biological weapon attacks (TW)
  • Who isn’t equipped for a pandemic or bioterror attack? The WHO (BOTAS)
  • Congress must fully fund battle against Zika and Ebola (Miami Herald)
  • While Latin America struggles over Zika, Haiti faces epidemic with a shrug (WaPo)
  • Apocalyptic pathogens, front line disease detectives, and One Health (Pandora Report)
  • CBER laboratories in the life sciences-biodefense complex (FDA)
  • Protect against bioterror – invest in bioscience to fight drug-resistant infections (Post Gazette)
  • Without federal funding, counties brace to confront Zika on their own (WaPo)
  • U.S. to help fund technology to eliminate Zika in blood supply (Reuters)
  • Obama veto threat looms over latest version of Zika funding bill (CIDRAP)
  • EU referendum: UK science wakes up to new future (BBC News)
  • The right(s) approach to Zika (The Lancet)

SELECT AGENTS

  • Ebola virus disease in children: towards better clinical management (The Lancet)
  • Study: Capsule-conjugate anthrax vaccine protects macaques (CIDRAP)
  • Emergent BioSolutions clears hurdle for anthrax vaccine facility (CNBC)
  • Human cases of plague, tularemia reported in New Mexico, Colorado (CIDRAP)
  • Two die in suspected anthrax outbreak in Kazakhstan (Reuters)

INFECTIOUS DISEASE COUNTERMEASURES

  • U.S. spurns AstraZeneca’s nasal spray flu vaccine as ineffective (Reuters)
  • ACIP votes down use of LAIV nasal spray for 2016-2017 flu season (CDC)
  • Inovio Pharma gets green signal to test Zika vaccine in human trial (Reuters)
  • Experimental Zika vaccine is approved for clinical trials for first time in US (STAT)
  • Pilot implementation program for RTS,S malaria vaccine candidate (PATH)
  • WHO to launch emergency yellow fever vaccination in Angola, Congo (Reuters)

OUTBREAK NEWS & THREAT SURVEILLANCE

  • WHO team investigating viral hemorrhagic fever outbreak in South Sudan (Kaiser)
  • Avian influenza in poultry in the Netherlands (Gov.UK)
  • Global epidemiology of avian influenza A H5N1 from 1997–2015 (The Lancet)
  • Stopping listeria required an arsenal of tools and an army of experts (APHL)
  • Cases of Zika virus disease in the United States (Kaiser)
  • MCR-1 findings in gulls show mobility of resistance threat (CIDRAP)
  • Yellow fever: the consequences of neglect (The Lancet)

CHEMICAL WEAPONS

  • Why I asked to be tear-gassed at Porton Down (The Telegraph)
  • The science of chemical forensics in chemical weapons investigations (OPCW)
  • Feds will review Hanford response to toxic vapors (Oregon Live)
  • Encapsulation of a nerve agent detoxifying enzyme by a zirconium MOF (ACS)
  • The scientific breakthroughs behind modern fabric (Newsworks)
  • Petraeus on ISIS, chemical weapons, and terrorism threat (CNN)
  • UN takes stock of landmark resolution on weapons proliferation (UN)

RESEARCH & TECH

  • They’re going to CRISPR people. What could possibly go wrong? (STAT)
  • Cancer is contagious among clams. What about us? (NY Times)
  • Roche announces availability of LightMix modular Zika virus assay (Reuters)
  • PositiveID’s mobile lab business completed 80 projects so far this year (PositiveID)
  • Organs-on-chips allow new views of human biology (Scientific American)
  • Mosquito bites may worsen viral infection (The Scientist)

HISTORICAL & SPECIAL INTEREST

  • CBRNE: What would Ramazzini have to say? (CBRNe Portal)
  • Did the microbe make me do it? A review of Infectious Madness (Tracking Zebra)
  • Iceland, horses, and Hendra: Greg on vacation (Pandora Report)
  • The value (and disvalue) of conducting secret science (Tracking Zebra)
  • The epidemiology of greyscale (Aetiology)

Related Posts

Biodefense Headlines – 12 March 2023
News Scan

Biodefense Headlines – 12 March 2023

March 12, 2023
Biodefense Headlines – 24 January 2023
News Scan

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023
News Scan

Biodefense Headlines – 17 January 2023

January 17, 2023
Biodefense Headlines – 10 January 2023
News Scan

Biodefense Headlines – 10 January 2023

January 10, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC